MEDICINE MAN TECHNOLOGIES, INC.  Management's Discussion and Analysis of Financial Condition and Results of Operations (Form 10-Q) |  MarketScreener

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener

Organicell Regenerative Medicine, Inc. responds to recent promotional activities as requested by OTC markets Davie, Florida – November 21, 2022 – Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) (“Organicell” or the “Company“) was requested by OTC Markets Group, Inc. (“OTC markets“) to release this statement on promotional activity regarding its common stock. On November 17, 2022, …

Organicell Regenerative Medicine: Responds to Recent Promotional Activities as Demand from OTC Markets – Form 8-K | MarketScreener Read More »